Is WHO Mpox Monitoring Window Too Short?
MDSpire News
December 10, 2025
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

In 37 high-confidence, PCR-confirmed clade Ib cases in Uvira, the median interval from exposure to rash onset was 13.6 days.
The estimated 95th percentile for rash onset was 32.3 days after exposure, although estimates in the incubation period’s right tail were more uncertain.
Median incubation was shorter after sexual exposure than after nonsexual exposure: 10.3 days vs 13.5 days.
Incubation estimates varied by epidemic phase, increasing from a median of 10 days before September 1, 2024, to 17 days later, alongside a shift toward nonsexual community transmission.
The authors noted that the findings could affect postexposure vaccination timing, but vaccine effectiveness data for longer windows are needed.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: